This Week on NeurologyLive® — October 30, 2023
Here's some of what is coming soon to NeurologyLive® this week.
FDA Approves Vamorolone for DMD, Tau Agent BIIB080 Shows Promising Results, Subcutaneous Lecanemab More Effective in Amyloid Removal
Neurology News Network for the week ending October 28, 2023. [WATCH TIME: 4 minutes]
NeurologyLive® Friday 5 — October 27, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending October 27, 2023.
This Week on NeurologyLive® — October 23, 2023
Solanezumab Fails A4 Alzheimer Study, FDA Lifts Hold on FREEDOM-DM1 Trial, CMS Announces Coverages of PET Amyloid-ß Imaging
Neurology News Network for the week ending October 21, 2023. [WATCH TIME: 3 minutes]
NeurologyLive® Friday 5 — October 20, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending October 20, 2023.
This Week on NeurologyLive® — October 16 2023
FDA Hands CRL to Patisiran, GBA1 Parkinson Trial Initiated, Levetiracetam Effective as First-Line Treatment in IGE Syndromes
Neurology News Network for the week ending October 14, 2023. [WATCH TIME: 3 minutes]
NeurologyLive® Friday 5 — October 13, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending October 13, 2023.
This Week on NeurologyLive® — October 9 2023
FDA Clears High Dose Cohort of CTI-1601, SOMNUM AI Device Approved, Intracranial Pressure Monitoring and TBI
Neurology News Network for the week ending October 7, 2023. [WATCH TIME: 3 minutes]
NeurologyLive® Friday 5 — October 6, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending October 6, 2023.
This Week on NeurologyLive® — October 2, 2023
AdComm Committee Downvotes NurOwn, ADELY01 Cleared for Trials, Axsome Pushes Back SYMPHONY Trial
Neurology News Network for the week ending September 30, 2023. [WATCH TIME: 4 minutes]
NeurologyLive® Friday 5 — September 29, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending September 29, 2023.
This Week on NeurologyLive® — September 25, 2023
FDA Approves AIRAscore, Pimavanserin Packing Label Updated, Blarcamesine Data Released
Neurology News Network for the week ending September 23, 2023. [WATCH TIME: 3 minutes]
NeurologyLive® Friday 5 — September 22, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending September 22, 2023.
This Week on NeurologyLive® — September 18, 2023
MS Treatments Linked With PML, Neflamapimod Effectiveness Based on P-Tau181 Levels, Nerivio Safe in Pregnant Women
Neurology News Network for the week ending September 16, 2023. [WATCH TIME: 3 minutes]
NeurologyLive® Friday 5 — September 15, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending September 15, 2023.
This Week on NeurologyLive® — September 11, 2023
CNM-Au8 Improves Survival in ALS, New Parkinson Risk Factor Identified, Pamrevlumab Falls Short in Phase 3 Study
Neurology News Network for the week ending September 9, 2023. [WATCH TIME: 3 minutes]
NeurologyLive® Friday 5 — September 8, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending September 8, 2023.
This Week on NeurologyLive® — September 4, 2023
Cell Therapy Bemdaneprocel Meets Primary Objective, Retinal Thickness in Parkinson Disease, TERIS Study Findings Published
Neurology News Network for the week ending September 2, 2023. [WATCH TIME: 3 minutes]
NeurologyLive® Friday 5 — September 1, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending September 1, 2023.
This Week on NeurologyLive® — August 28, 2023
DT-216 Reduces Frataxin Levels in FA, Valbenazine FDA-Approved for Huntington Chorea, EU Approves Atogepant as Migraine Preventive
Neurology News Network for the week ending August 26, 2023. [WATCH TIME: 3 minutes]
NeurologyLive® Friday 5 — August 25, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending August 25, 2023.